ST
CYTK icon

Spot Trading’s Cytokinetics CYTK Stock Holding History

Spot Trading’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$183K Buy
+12,600
New +$172K ﹤0.01% 2282
2016
Q2 		– Sell
-14,000
Closed -$99K – 3391
2016
Q1 		$99K Hold
14,000
– – ﹤0.01% 2570
2015
Q4 		$146K Sell
14,000
-26,900
-66% -$264K ﹤0.01% 2632
2015
Q3 		$274K Buy
+40,900
New +$279K ﹤0.01% 2478
2014
Q3 		– Sell
-2,500
Closed -$12K – 4370
2014
Q2 		$12K Buy
+2,500
New +$15.3K ﹤0.01% 4259

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Spot Trading's CYTK Position: Q3 2017 in Review

Spot Trading opened a new position in Cytokinetics (CYTK) in Q3 2017: 2,659 shares worth $39K. The stake represents ﹤0.01% of the portfolio and ranks #2785 among its holdings. This is a return to the name: Spot Trading previously reported a position in CYTK as recently as Q4 2015.

Spot Trading first reported a position in CYTK in Q1 2014 and has held it in 5 quarters since. The position peaked at $2.52M in Q1 2014. 132 funds tracked by Wall St. Rank hold CYTK as of Q3 2017.

  • Spot Trading held 2,659 shares of Cytokinetics worth $39K as of Q3 2017.
  • Cytokinetics was a new Spot Trading position in Q3 2017.
  • Cytokinetics made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2785 holding.
  • Spot Trading first reported a position in Cytokinetics in Q1 2014 and has held it in 5 quarters since.
  • Spot Trading's Cytokinetics position peaked at $2.52M in Q1 2014.
  • 132 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.